Evidence map›Paper›PMID 42534748›Full record

ArticleFrontiers in oncology2026

PET/CT false-negative angioimmunoblastic T-cell lymphoma: a case report and literature review.

Yiling Bai, Yisong Xiong, Hengning Lian, Guangqing Shi, Yue Teng, Lijie Ma

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yiling Bai *Department of Pulmonary and Critical Care Medicine, General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Yisong Xiong *Department of Clinical Laboratory, General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Hengning LianDepartment of Pulmonary and Critical Care Medicine, General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Guangqing ShiDepartment of Pulmonary and Critical Care Medicine, General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Yue TengDepartment of Pulmonary and Critical Care Medicine, General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Lijie MaDepartment of Pulmonary and Critical Care Medicine, General Hospital of Western Theater Command, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) is a peripheral T-cell lymphoma characterized by heterogeneous clinical and immunologic manifestations. We report a 65-year-old female whose morphologically abnormal superficial lymph nodes were fluoro-D-glucose (FDG)-negative on positron emission tomography/computed tomography (PET/CT), while deep mediastinal and hilar nodes were hypermetabolic. Initial biopsies of FDG-avid sites were non-diagnostic. Definitive diagnosis was ultimately achieved via excisional biopsy of a superficial node. This case underscores that AITL may exhibit PET/CT false-negativity, highlighting the need for integrating clinical, laboratory, flow cytometry, and histopathologic data to avoid diagnostic delays.

Indexed as

angioimmunoblastic T-cell lymphoma (AITL)case reportlymph node biopsymultimodal diagnostic approachPET/CT false-negativity

Identifiers

PMID42534748
PMCPMC13421432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.